CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 300 enrolled
Drug / intervention
A specific electrophysiology mapping protocol is applicable with the GRID catheter.procedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03882021
NCT03882021N/ACompleted

High-Density (HD) Wave Mapping in Subjects With Atrial Fibrillation as a Predictor of Recurrence After a Single Ablation Procedure Using a PVI-Only Strategy

Abbott Medical Devices·interventional·Posted Mar 20, 2019·Updated Sep 19, 2024

In Brief

A clinical study evaluating A specific electrophysiology mapping protocol is applicable with the GRID catheter. for Paroxysmal Atrial Fibrillation and 2 related conditions. Completed, enrolled 300 participants across 15 sites in 9 countries.

Detailed Summary

The aim is to use the Advisor™ HD Grid Mapping Catheter, Sensor Enabled™ to characterize the atrial substrate and develop a model for predicting recurrence rates after a single procedure using a PVI only approach and a contact catheter.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesAustria, Czechia, France, Germany, Italy, Netherlands, Portugal, Spain, United Kingdom
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedMar 20, 2019
Enrollment StartAug 26, 2019
Primary CompletionNov 30, 2021
Study CompletionJan 13, 2022
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 7.3 years ago

Interventions

A specific electrophysiology mapping protocol is applicable with the GRID catheter.procedure

The procedure will be done according to a standard ablation approach. During the electrophysiology study, additional mapping data will be collected to support the study endpoints using the GRID catheter.